Other Biogen Idec Target definition

Other Biogen Idec Target means a Target that has been designated as an Other Biogen Idec Target in accordance with Section 2.5.6 or 2.5.7, provided that any Target that is removed as an Other Biogen Idec Target pursuant to Section 2.5.8 after being so designated shall no longer be considered a Other Biogen Idec Target.

Examples of Other Biogen Idec Target in a sentence

  • A Party (the “Requesting Party”) requesting to designate a Target (a “Requested Target”) as either a Sunesis Target or an Other Biogen Idec Target shall provide the other Party (the “Receiving Party”) in writing with a Diligence Summary and proposed Selectivity Parameters for the Requested Target.

  • After designation of a Requested Target as an Other Biogen Idec Target or Sunesis Target (excluding for purposes of this Section 2.5.8, the Sunesis Target designated under Section 2.5.3), the Party so designating shall provide the other Party with a Diligence Summary six months after such designation, and upon each anniversary of such date for so long as such Target remains an Other Biogen Idec Target or Sunesis Target, as applicable.

  • For the purposes of determining whether such licenses are “previously granted” as used in this Section 6.4, the exclusive licenses set forth in Sections 6.2.1, 6.3.1(b) and 6.3.2(b) shall be considered separate licenses for each Collaboration Target, Other Biogen Idec Target and Sunesis Target, respectively, and each separate Target-specific license shall be deemed granted as of the date of designation of such Target as a Collaboration Target, Other Biogen Idec Target or Sunesis Target, as applicable.

  • Upon notice to the requesting Party that such Target is Available, such Target shall be designated as an Other Biogen Idec Target or a Sunesis Target, as applicable.

  • We manually inspected weekly wages in the tails of the distribution, including checking the original advertisements, and corrected the frequency if appropriate, or, more rarely, the raw wage itself.

Related to Other Biogen Idec Target

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • GSK will have the meaning set forth in the Preamble.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • ISIS means the department’s individualized services information system.

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Soft Target means a target that will suffer minimum damage and cause minimum damage to the subject vehicle in the event of a collision.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;

  • Research Program Term has the meaning set forth in Section 2.2.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Research Term has the meaning set forth in Section 3.2.

  • Novartis shall have the meaning set forth in the Preamble.

  • Research Program has the meaning set forth in Section 2.1.

  • Merck has the meaning set forth in the preamble.

  • Collaboration Term has the meaning set forth in Section 2.1(h).

  • JRC has the meaning set forth in Section 2.1.1.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Licensed Compound means [***].

  • Research Plan shall have the meaning set forth in Section 2.1.

  • JSC has the meaning set forth in Section 3.1.

  • Independent candidate means any candidate who claims not to be affiliated with a political party, and whose name has been certified on the office-type ballot at a general or special election through the filing of a statement of candidacy and nominating petition, as prescribed in section 3513.257 of the Revised Code.

  • Development Term means the period commencing on the Closing Date and ending on the earlier of (a) the Option Closing Date or (b) the date the Option terminates or expires other than by exercise.

  • Collaboration has the meaning set forth in Section 2.1.

  • Joint Commercialization Committee or “JCC” has the meaning set forth in Section 3.4 (Joint Commercialization Committee).

  • Development Program means the implementation of the development plan.